Compugen (CGEN) Total Current Liabilities (2009 - 2026)
Compugen's (CGEN) quarterly Total Current Liabilities came in at $22.0 million in Q1 2026, up 4.97% year-on-year from $21.0 million in Q1 2025, and down 2.36% quarter-over-quarter from $22.6 million in Q4 2025.
Compugen (CGEN) Total Current Liabilities (2009 - 2026) Analysis & Trends
Compugen has disclosed Total Current Liabilities across 18 years of filings, most recently posting $22.0 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $22.0 million, up 4.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.0 million (up 4.97% YoY), and the FY2025 annual result was $22.6 million, up 11.95% from the prior year.
- Total Current Liabilities came in at $22.0 million for Q1 2026 at Compugen, down from $22.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $27.8 million in Q3 2024 to a low of $10.4 million in Q3 2023.
- The 5-year median for Total Current Liabilities is $20.3 million (2025), against an average of $18.7 million.
- Across the five-year window, Total Current Liabilities sank 31.74% in 2023 and soared 167.55% in 2024, its largest moves.
- Compugen's Total Current Liabilities stood at $11.9 million in 2022, then soared by 120.37% to $26.3 million in 2023, then decreased by 23.25% to $20.2 million in 2024, then advanced by 11.95% to $22.6 million in 2025, then slipped by 2.36% to $22.0 million in 2026.
- The last three Total Current Liabilities figures came in at $22.0 million (Q1 2026), $22.6 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 22.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.04 Mn |
| Dec 31, 2025 | 22.57 Mn |
| Sep 30, 2025 | 20.28 Mn |
| Jun 30, 2025 | 20.58 Mn |
| Mar 31, 2025 | 20.99 Mn |
| Dec 31, 2024 | 20.16 Mn |
| Sep 30, 2024 | 27.76 Mn |
| Jun 30, 2024 | 24.77 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 26.27 Mn |
| Sep 30, 2023 | 10.38 Mn |
| Jun 30, 2023 | 10.80 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 11.92 Mn |
| Sep 30, 2022 | 14.77 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Mar 31, 2022 | 15.70 Mn |
| Dec 31, 2021 | 17.10 Mn |
| Sep 30, 2021 | 15.26 Mn |
| Jun 30, 2021 | 11.85 Mn |